Role of ATP-sensitive potassium channels in the biphasic effects of morphine on pentylenetetrazole-induced seizure threshold in mice

Epilepsy Research

Volumn 75, Issue 1, 2007, Pages 63-69

  Shafaroodi, Hamed ^a   Asadi, Shahrzad ^b   Sadeghipour, Hamed ^c   Ghasemi, Mehdi ^c   Ebrahimi, Farzad ^c   Tavakoli, Sina ^c   Hajrasouliha, Amir Reza ^c   Dehpour, Ahmad Reza ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ATP sensitive potassium channel; Clonic seizure threshold; Mice; Morphine; Pentylentetrazole

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CROMAKALIM; DIMETHYL SULFOXIDE; GLIBENCLAMIDE; GLUCOSE; MORPHINE SULFATE; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE INCREASE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SEIZURE THRESHOLD; SINGLE DRUG DOSE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; CROMAKALIM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLYBURIDE; HYPOGLYCEMIC AGENTS; MALE; MICE; MORPHINE; NARCOTICS; PENTYLENETETRAZOLE; POTASSIUM CHANNELS; SEIZURES; SEVERITY OF ILLNESS INDEX;

EID: 34249794550     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2007.04.005     Document Type: Article

References (41)

1. Alarcon S., Hernandez J., and Laorden M.L. Diazoxide blocks the morphine induced lengthening of action potential duration on guinea-pig papillary muscle. Gen. Pharmacol. 26 (1995) 589-592
2. + channels. Science 247 (1990) 852-854
3. ATP channels. Circ. Res. 89 (2001) 273-278
4. De Weille J.R., and Lazdunski M. Regulation of the ATP-sensitive potassium channels. Ion Channels 2 (1990) 205-222
5. Foote F., and Gale K. Proconvulsant effect of morphine on seizures induced by pentylentetrazole in the rat. Eur. J. Pharmacol. 105 (1984) 179-184
6. Gale K. Role of the substantia nigra in GABA-mediated anticonvulsant actions. Adv. Neurol. 44 (1986) 343-364
7. Garant D.S., and Gale K. Infusion of opiates into substantia nigra protects against maximal electroshock seizures in rats. J. Pharmacol. Exp. Ther. 234 (1985) 45-48
8. 3H]glibenclamide binding to mouse forebrain membranes during morphine tolerance. Eur. J. Pharmacol. 418 (2001) 29-37
9. 3H]glibenclamide binding sites within the substantia nigra zona reticulata of the rat brain. Neuroscience 61 (1994) 285-292
10. Homayoun H., Khavandgar S., and Dehpour A.R. The involvement of endogenous opioids and nitricoxidergic pathway in the anticonvulsant effects of foot-shock stress in mice. Epilepsy Res. 49 (2002) 131-142
11. Homayoun H., Khavandgar S., Namiranian K., Gaskari S.A., and Dehpour A.R. The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res. 48 (2002) 33-41
12. Iadarola M.J., and Gale K. Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science 218 (1982) 1237-1240
13. + channel, in the model of hippocampus-generating partial seizures in rats. Eur. J. Pharmacol. 311 (1996) 37-44
14. Khavandgar S., Homayoun H., and Dehpour A.R. Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice. Pharmacol. Biochem. Behav. 74 (2003) 795-801
15. Lauretti G.R., Ahmad I., and Pleuvry B.J. The activity of opioid analgesics in seizure models utilizing N-methyl-dl-aspartic acid, kainic acid, bicuculline and pentylenterazole. Neuropharmacology 33 (1994) 155-160
16. Loscher W., Honack D., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III Pentylenetetrazole seizure models. Epilepsy Res. 8 (1991) 171-189
17. Lufty K., Woodward R.M., Keana J.F., and Weber E. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACE-1011. Eur. J. Pharmacol. 252 (1994) 261-266
18. Narita M., Suzuki T., Misawa M., Nagase H., Nabeshima A., Ashizawa T., Ozawa H., et al. Role of central ATP-sensitive potassium channels in the analgesic effect and spinal noradrenaline turnover-enhancing effect of interacerebroventricularly injected morphine in mice. Brain Res. 596 (1992) 209-214
19. Narita M., Suzuki T., Misawa M., and Nagase H. Role of central ATP-sensitive potassium channels in the hyperthermic effect of morphine in mice. Psychopharmacology (Berl) 109 (1992) 239-240
20. Narita M., Takahashi Y., Suzuki T., Misawa M., and Nagasa H. An ATP-sensitive potassium channel blocker abolishes the potentiating effect of morphine on the bicuculline-induced convulsion in mice. Psychopharmacology (Berl) 110 (1993) 500-502
21. North R.A. Twelfth Gaddum memorial lecture. Drug receptors and the inhibition of nerve cells. Br. J. Pharmacol. 98 (1989) 13-28
22. + channels-acting drugs. Br. J. Pharmacol. 114 (1995) 1296-1302
23. 2 adrenoceptors, γ-aminobutyric acid(B), mu and kappa opioid receptors. J. Pharmacol. Exp. Ther. 276 (1996) 1136-1142
24. Pavone F., Castellano C., and Oliverio A. Strain-dependent effects of shock-induced release of opioids: dissociation between analgesia and behavioral seizures. Brain Res. 366 (1986) 326-328
25. Pena F., and Tapia R. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels. Neuroscience 101 (2000) 547-561
26. + channel openers delay intestinal transit and have antidiarrheal activity. Eur. J. Pharmacol. 287 (1995) 207-209
27. Raffa B.R., and Martinez R.P. The 'glibenclamide-shift' of centrally-acting antinociceptive agents in mice. Brain Res. 677 (1995) 277-282
28. + channel openers inhibit morphine withdrawal. Eur. J. Pharmacol. 251 (1994) 113-115
29. + channels. Br. J. Pharmacol. 129 (2000) 110-114
30. Sagratella S., and Massotti M. Convulsant and anticonvulsant effects of opioids: relationship to GABA-mediated transmission. Neuropharmacology 21 (1982) 991-1000
31. + channels and block neurosecretion. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3489-3492
32. + channel in neurons of substantia nigra pars reticulata. Naunyn. Schmiedebergs. Arch. Pharmacol. 348 (1993) 113-117
33. Shafaroodi H., Samini M., Moezi L., Homayoun H., Sadeghipour H., Tavakoli S., Hajrasouliha A.R., and Dehpour A.R. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology 47 (2004) 390-400
34. Stanford I.M., and Lacey M.G. Electrophysiological investigation of adenosine trisphosphate-sensitive potassium channels in the rat substantia nigra pars reticulata. Neuroscience 74 (1996) 499-509
35. Stefani M.R., Nicholson G.M., and Gold P.E. ATP-sensitive potassium channel blockade enhances spontaneous alternation performance in the rat: a potential mechanism for glucose-mediated memory enhancement. Neuroscience 93 (1999) 557-563
36. Turski W.A., Bortolotto Z.A., Ikonomidou-Turski C., Moraes Mello L.E., Cavalheiro E.A., and Turski L. The threshold for limbic seizures in rats is decreased by intranigral morphine. NIDA Res. Monogr. 75 (1986) 547-550
37. Wikler A., and Altschul S. Effects of methadone and morphine on the electroencephalogram of the dog. J. Pharmacol. Exp. Ther. 98 (1950) 437-446
38. ATP channels. J. Mol. Cell Cardiol. 38 (2005) 945-949
39. Yamada K., Ji J.J., Yuan H., Miki T., Sato S., Horimoto N., Shimizu T., Seino S., and Inagaki N. Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science 292 (2001) 1543-1546
40. Zarrindast M.R., Jafari M.R., Shafaghi B., and Djahanguiri B. Influence of potassium channel modulators on morphine state-dependent memory of passive avoidance. Behav. Pharmacol. 15 (2004) 103-110
41. Zieglgänsberger W., French E.D., Siggins G.R., and Bloom F.E. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science 205 (1979) 415-417